EFFECTS OF INFLAMMATORY DISEASE ON PLASMA OXPRENOLOL CONCENTRATIONS

被引:27
作者
KENDALL, MJ
QUARTERMAN, CP
BISHOP, H
SCHNEIDER, RE
机构
[1] Department of Therapeutics and Clinical Pharmacology, Queen Elizabeth Hospital
关键词
D O I
10.1136/bmj.2.6188.465
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
When single oral doses of oxprenolol were given to three healthy subjects on three separate occasions under standardised conditions the plasma concentration-time curves for each subject were closely similar. In two of the subjects, however, a mild illness led to a dramatic, temporary increase in the peak plasma concentration and area under the plasma concentration-time curve (AUC). This effect of inflammatory disease was confirmed by comparing a group of patients with an erythrocyte sedimentation rate (ESR) of over 20 mm in the first hour with a group whose ESR was below this value. The mean peak plasma concentration and AUC were significantly higher in the group with a raised ESR. This may be related to altered concentrations of one of the acute-phase proteins. Thus it is concluded that plasma oxprenolol concentrations are raised in inflammatory disease, but further work is needed to determine the mechanism of this increase. © 1979, British Medical Journal Publishing Group. All rights reserved.
引用
收藏
页码:465 / 468
页数:4
相关论文
共 11 条
  • [1] RELATION BETWEEN PLASMA CONCENTRATIONS AND CARDIOVASCULAR EFFECTS OF ORAL OXPRENOLOL IN MAN
    BRUNNER, L
    IMHOF, P
    JACK, D
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1975, 8 (01) : 3 - 9
  • [2] DETERMINATION OF LOW-LEVELS OF OXPRENOLOL IN BLOOD OR PLASMA BY GAS-LIQUID-CHROMATOGRAPHY
    JACK, DB
    RIESS, W
    [J]. JOURNAL OF CHROMATOGRAPHY, 1974, 88 (01): : 173 - 176
  • [3] KENDALL MJ, 1976, EUR J DRUG METAB PHA, V3, P155
  • [4] MASON WD, 1976, CLIN PHARMACOL THER, V20, P401
  • [5] INCREASED PLASMA-PROTEIN BINDING OF PROPRANOLOL AND CHLORPROMAZINE MEDIATED BY DISEASE-INDUCED ELEVATIONS OF PLASMA ALPHA-1-ACID GLYCOPROTEIN
    PIAFSKY, KM
    BORGA, O
    ODARCEDERLOF, I
    JOHANSSON, C
    SJOQVIST, F
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1978, 299 (26) : 1435 - 1439
  • [6] PHARMACOKINETIC CHARACTERISTICS OF BETA-RECEPTOR-ANTAGONISTS IN MAN - SIMILARITIES AND DIFFERENCES OF CLINICAL RELEVANCE
    RIESS, W
    BRECHBUHLER, S
    THEOBALD, W
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 1976, 6 : 4 - 13
  • [7] METABOLITES OF OXPRENOLOL (TRASICOR) IN MAN
    RIESS, W
    HUERZELER, H
    RASCHDORF, F
    [J]. XENOBIOTICA, 1974, 4 (06) : 365 - 373
  • [8] SCHNEIDER RE, 1979, LANCET, V1, P554
  • [9] PLASMA-LEVELS OF PROPRANOLOL IN TREATED PATIENTS WITH CELIAC-DISEASE AND PATIENTS WITH CROHNS-DISEASE
    SCHNEIDER, RE
    BABB, J
    BISHOP, H
    MITCHARD, M
    HOARE, AM
    HAWKINS, CF
    [J]. BRITISH MEDICAL JOURNAL, 1976, 2 (6039) : 794 - 795
  • [10] COMPARISON OF SLOW RELEASE WITH CONVENTIONAL OXPRENOLOL - PLASMA CONCENTRATIONS AND CLINICAL EFFECTS
    WEST, MJ
    KENDALL, MJ
    MITCHARD, M
    FARAGHER, EB
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1976, 3 (03) : 439 - 443